Concepedia

Stephen Clarke

SC

272

Publications

21.3K

Citations

72

H-Index

1972

Active since

Affiliations

The University of Sydney(Current)

Royal North Shore Hospital

Concord Repatriation General Hospital

Royal Prince Alfred Hospital

Asbestos Diseases Research Institute

Stephen Clarke is an author at The University of Sydney specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1972–2024

272

Publications

272

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 3K citations · Full text

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 858 citations · Full text

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van Zandwijk, Nick Pavlakis, Steven Kao et al. · The Lancet Oncology · 2017 · 681 citations

, , +8

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

, , +14

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll et al. · The Lancet Oncology · 2012 · 522 citations

, , +7

Rows per page

1–5 of 272